The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus

T Tomoyuki Shiota (Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill) Y Yuguang Zhao (Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford) I Itoe Shiota (Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill) H Helen M. E. Duyvesteyn (Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford) M Manami Yamaoka (Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe) A Anshuman Das (Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill) M Maryna Kapustina (Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill) P Pranav Shah (Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford) M Masamichi Muramatsu (Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe) X Xiangxi Wang (State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences) E Elizabeth E. Fry (Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford) D David I. Stuart (Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford) S Stanley M. Lemon (Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill)

Abstract

Hepatitis A virus (HAV) is an unusual picornavirus with two types of extracellular virions: nonenveloped particles (nHAV) shed in feces and quasi-enveloped particles (eHAV) circulating in blood. Both enter cells by clathrin-dependent endocytic pathways merging in late endolysosomes with capsid binding to ganglioside receptors. Phosphatidylserine receptors facilitate eHAV endocytosis, but no protein receptor has been identified for nHAV. Here, we show low-density lipoprotein receptor (LDLR) is such a receptor. LDLR knockout did not alter viral attachment to cells, but restricted cellular uptake of nHAV (not eHAV). Soluble LDLR ectodomain blocked nHAV entry, as did antibody to LDLR. Recombinant LDLR-related protein-associated protein 1, a pan-LDLR family chaperone, also inhibited nHAV entry, including residual entry into knockout cells, suggesting other LDLR family members may similarly facilitate endocytosis. Reconstituting full-length LDLR expression restored nHAV entry in knockout cells, whereas LDLR mutants lacking LA repeats 4 to 7 or the EGF-like/propeller domain did not. ELISAs confirmed LDLR binds nHAV, optimally above pH7, without destabilizing the capsid. A 1.7Å resolution cryoelectron microscopy (cryo-EM) structure revealed LDLR interacts with VP1 at the fivefold vertex of the capsid. Extreme blurring of the LDLR density prevented detailed identification of LDLR interactions, and suggested binding does not follow particle symmetry, being either flexible or to multiple LDLR regions. Additional cryo-EM studies show ganglioside GD1a binds to a similar region of the capsid. Collectively, these data reveal the LDLR to be an important entry factor, shuttling nHAV from the extracellular environment to endolysosomes where it is likely released at low pH to bind gangliosides.

Article Details

Volume / Issue Vol. 123, Issue 14
Published April 07, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (13)

T

Tomoyuki Shiota

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill

Y

Yuguang Zhao

Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford

I

Itoe Shiota

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill

H

Helen M. E. Duyvesteyn

Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford

M

Manami Yamaoka

Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe

A

Anshuman Das

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill

M

Maryna Kapustina

Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill

P

Pranav Shah

Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford

M

Masamichi Muramatsu

Department of Infectious Disease Research, Foundation for Biomedical Research and Innovation at Kobe

X

Xiangxi Wang

State Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences

E

Elizabeth E. Fry

Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford

D

David I. Stuart

Division of Structural Biology, Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford

S

Stanley M. Lemon

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill